Drug Utilization Study With Intuniv® in Australia
Latest Information Update: 06 Oct 2021
At a glance
- Drugs Guanfacine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Shire; Takeda
- 27 Sep 2021 Status changed from active, no longer recruiting to completed.
- 05 May 2021 New trial record